A phase I study of Triapine [OCX 0191] in combination with radiation therapy in locally advanced pancreas cancer

Trial Profile

A phase I study of Triapine [OCX 0191] in combination with radiation therapy in locally advanced pancreas cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs OCX 191 (Primary)
  • Indications Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 18 Jul 2012 Planned end date changed from 1 Aug 2007 to 1 Jan 2100 as reported by ClinicalTrials.gov
    • 25 Feb 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov, last updated 25-2-2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top